A

Arena Pharmaceuticals Inc
F:RN3N

Watchlist Manager
Arena Pharmaceuticals Inc
F:RN3N
Watchlist
Price: 90.5 EUR 0.56% Market Closed
Market Cap: 5.6B EUR

Relative Value

RN3N price has not been updated for more than 10 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of RN3N.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RN3N Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
111 990.6
Median 5Y
110 055.4
Industry
7.9
Forward
255.2
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-9.8
Industry
23.7
Forward
-12.2
vs History
vs Industry
Median 3Y
-13.4
Median 5Y
-13.2
Industry
22
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.3
Industry
24.3
vs History
vs Industry
Median 3Y
9
Median 5Y
8.8
Industry
3.3
vs History
vs Industry
Median 3Y
102 466.3
Median 5Y
100 531.1
Industry
8.2
Forward
235.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.2
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-10
Industry
6.1
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-10
Industry
6.5
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-12
Industry
7.9
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-10.4
Industry
6.3
vs History
vs Industry
Median 3Y
25
Median 5Y
25
Industry
5.7

Multiples Across Competitors

RN3N Competitors Multiples
Arena Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Arena Pharmaceuticals Inc
F:RN3N
5.6B EUR 121 242 -10.6 -11.1 -11.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 766 261.7 -160 486 -194 881.2 -192 657.4
US
Abbvie Inc
NYSE:ABBV
406.4B USD 6.8 172.7 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
177B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
153.1B USD 5.2 18.8 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 9.8 31.4 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.4 -532.4 -579.7 -564.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.5B USD 5.7 17.8 17 19.3
AU
CSL Ltd
ASX:CSL
83.6B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD 16.4 1 206.2 162.6 197.3
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.3 33.6 57.9 59.5
P/E Multiple
Earnings Growth PEG
US
A
Arena Pharmaceuticals Inc
F:RN3N
Average P/E: 190.5
Negative Multiple: -10.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 486 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.8
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 206.2
N/A N/A
NL
argenx SE
XBRU:ARGX
33.6
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
A
Arena Pharmaceuticals Inc
F:RN3N
Average EV/EBITDA: 40.1
Negative Multiple: -11.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 881.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.6
N/A N/A
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
A
Arena Pharmaceuticals Inc
F:RN3N
Average EV/EBIT: 46.3
Negative Multiple: -11.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 657.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.3
N/A N/A
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A